Investment banking firm Jefferies raises Eli Lilly's price target based on optimism over orfoscerinib, indicating strong confidence in its potential. ...
Greenfield Partners is thriving in the competitive venture capital landscape, managing $1 billion in funds and prioritizing investments in high-growth ...